Denosumab for management of refractory hypercalcaemia in recurrent parathyroid carcinoma

被引:11
作者
Nadarasa, K. [1 ]
Theodoraki, A. [2 ]
Kurzawinski, T. R. [3 ]
Carpenter, R. [1 ]
Bull, J. [4 ]
Chung, T. T. [2 ]
Drake, W. M. [1 ]
机构
[1] St Bartholomews Hosp, Dept Endocrinol, London, England
[2] UCLH NHS Fdn Trust, Dept Endocrinol & Diabet, London, England
[3] UCLH NHS Fdn Trust, Dept Endocrine Surg, London, England
[4] Royal London Hosp, Dept Neurosurg, London E1 1BB, England
关键词
D O I
10.1530/EJE-14-0482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:L7 / L8
页数:2
相关论文
共 5 条
[1]   Resistant hypercalcaemia in metastatic parathyroid carcinoma [J].
Bowyer, Samantha E. ;
White, Alison M. ;
Ransom, David T. ;
Davidson, John A. .
MEDICAL JOURNAL OF AUSTRALIA, 2013, 198 (10) :559-561
[2]   Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab [J].
Karuppiah, Dharshini ;
Thanabalasingham, Gaya ;
Shine, Brian ;
Wang, Lai Mun ;
Sadler, Gregory P. ;
Karavitaki, Niki ;
Grossman, Ashley B. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (01) :K1-K5
[3]   Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases [J].
Ruggiero, SL ;
Mehrotra, B ;
Rosenberg, TJ ;
Engroff, SL .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (05) :527-534
[4]   Denosumab for Management of Parathyroid Carcinoma-Mediated Hypercalcemia [J].
Vellanki, Priyathama ;
Lange, Karoline ;
Elaraj, Dina ;
Kopp, Peter A. ;
El Muayed, Malek .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (02) :387-390
[5]   Parathyroid Carcinoma: Update and Guidelines for Management [J].
Wei, Christina H. ;
Harari, Avital .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (01) :11-23